Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Friedland

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIVGerald Friedland, Saye Khoo, Christopher Jack, et al.
Current Opinion in Infectious Diseases|June 18, 2009
Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV communitySheela Shenoi, Scott Heysell, Anthony Moll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigationsFarzana Kapadia, David Vlahov, Robert M Donahoe, et al.
The Lancet. Infectious Diseases|June 1, 2010
Opportunities afforded by new drugs for tuberculosisGavin J Churchyard, Gerald Friedland, Katherine Fielding, et al.
Global Health Promotion|June 26, 2013
An inter-professional 'advocacy and activism in global health': module for the training of physician-advocatesMichael J Peluso, Brian Seavey, Gregg Gonsalves, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trialsSharon Mannheimer, Gerald Friedland, John Matts, et al.
AIDS and Behavior|May 14, 2020
Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 ResponseE Jennifer Edelman, Lydia Aoun-Barakat, Merceditas Villanueva, et al.
Lancet (London, England)|February 8, 2003
Antiretroviral treatment and research in resource-poor countriesRobert Pawinski, Raziya Bobat, Gerald Friedland, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|February 18, 2017
Contextual Noise Reduction for Domain Adaptive Near-Duplicate Retrieval on Merchandize ImagesZhen-Qun Yang, Xiao-Yong Wei, Zhang Yi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2003
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patientsElinore F McCance-Katz, Petrie M Rainey, Gerald Friedland, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIVGerald Friedland, Saye Khoo, Christopher Jack, et al.
Current Opinion in Infectious Diseases|June 18, 2009
Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV communitySheela Shenoi, Scott Heysell, Anthony Moll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigationsFarzana Kapadia, David Vlahov, Robert M Donahoe, et al.
The Lancet. Infectious Diseases|June 1, 2010
Opportunities afforded by new drugs for tuberculosisGavin J Churchyard, Gerald Friedland, Katherine Fielding, et al.
Global Health Promotion|June 26, 2013
An inter-professional 'advocacy and activism in global health': module for the training of physician-advocatesMichael J Peluso, Brian Seavey, Gregg Gonsalves, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trialsSharon Mannheimer, Gerald Friedland, John Matts, et al.
AIDS and Behavior|May 14, 2020
Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 ResponseE Jennifer Edelman, Lydia Aoun-Barakat, Merceditas Villanueva, et al.
Lancet (London, England)|February 8, 2003
Antiretroviral treatment and research in resource-poor countriesRobert Pawinski, Raziya Bobat, Gerald Friedland, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|February 18, 2017
Contextual Noise Reduction for Domain Adaptive Near-Duplicate Retrieval on Merchandize ImagesZhen-Qun Yang, Xiao-Yong Wei, Zhang Yi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2003
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patientsElinore F McCance-Katz, Petrie M Rainey, Gerald Friedland, et al.
Pageof 11